Next Day Disclosure Return
Filed with HKEX · Stock code 9926 · · 6 pages · English
Earlier from Akeso
- Completion of placing of new shares under general mandate
- Placing of new shares under general mandate
- Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2026
- 2026 Interim report
- Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer
Later from Akeso
All Akeso news releasesFollow Akeso into a list and get an email when it puts out news.
Follow Akeso